Jami Rubin analyst

Currently out of the existing stock ratings of Jami Rubin, 39 are a BUY (60.94%), 17 are a HOLD (26.56%), 8 are a SELL (12.5%).

Jami Rubin

Work Performance Price Targets & Ratings Chart

Analyst Jami Rubin works with a stock forecast success ratio of 84.62% fulfilled within 486.31 days on average. Previously, Jami Rubin worked at GOLDMAN SACHS.

Jami Rubin’s has documented 143 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 01-Oct-2018.

Wall Street Analyst Jami Rubin

Analyst best performing recommendations are on ALNY (ALNYLAM PHARMACEUTICALS).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) at 11/6/2017. The price target of $13 was fulfilled within 11 days with a profit of $0.67 (5.43%) receiving and performance score of 4.94.

Average potential price target upside

ABBV AbbVie AGN Allergan plc BMY Bristol-Myers Squibb Company JNJ Johnson & Johnson MRK Merck mpany MYL Viatris PRGO Perrigo Company PLC TEVA Teva Pharma Industries Ltd ADR LLY Eli Lilly and Company PFE Pfizer VTRS Viatris ALNY Alnylam Pharmaceuticals ZTS Zoetis

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

195

$25.2 (14.84%)

185

22 days ago

10/12 (83.33%)

$14.65 (8.12%)

191

Buy

189

$19.2 (11.31%)

181

2 months 12 days ago

9/11 (81.82%)

$15.71 (9.07%)

252

Buy

195

$25.2 (14.84%)

180

2 months 12 days ago

9/10 (90%)

$21.71 (12.53%)

445

Hold

165

$-4.8 (-2.83%)

157

3 months 1 days ago

11/11 (100%)

$2.96 (1.83%)

314

Buy

180

$10.2 (6.01%)

195

3 months 15 days ago

3/5 (60%)

$21.06 (13.25%)

496

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jami Rubin?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?